House Panel May Subpoena FDA Investigators To Address Ketek Safety Study

Agency foot-dragging over questions regarding approval of the Sanofi-Aventis antibiotic leads House Energy and Commerce subcommittee to consider forcing testimony.

More from Archive

More from Pink Sheet